🔎 Trials Near Me

Akèy › Kansè san › Oregon › Portland

Etid klinik pou Kansè san nan Portland, OR

7 etid pou Kansè san ap chèche patisipan nan sit nan ak bò kote Portland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Ap rekriteEtid obsèvasyon
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Portland VA Medical Center, Portland
  • ak 1 plis
Tout laj · Tout sèks · Mizajou Oct 5, 2026 · NCT04242095

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Ap rekriteFaz 2
  • Oregon Health and Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • Oregon Health & Science University/Doernbecher Children's Hospital, Portland
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

IVIG for Infection Prevention After CAR-T-Cell Therapy

Ap rekriteFaz 2
  • Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05952804

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Ap rekriteFaz 1/2
  • Providence Neurological Specialties West, Portland
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Oregon Health & Science University, Portland
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Kansè san nan lòt vil

Lòt etid nan Portland

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.